 |
Teniposide |
|---|---|
| Trade Name | Vumon For Injection |
| Orphan Indication | Refractory childhood acute lymphocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 1984-11-01 00:00:00 |
| Sponsor | Bristol-Myers Squibb Pharmaceutical Research Institute;5 Research Parkway, P.O. Box 5100;Wallingford, Connecticut, 06492 |
